|Day Low/High||36.55 / 39.66|
|52 Wk Low/High||13.35 / 53.99|
Quite a few stocks are fading right now -- not due to poor fundamentals, but due to lack of buying interest.
Study those charts and be ready to act as things develop.
Forte's sole clinic candidate is FB-401 for the treatment of atopic dermatitis, which is the scientific name for eczema.
While I remain quite bullish, I am trying to strategize a bit to deal with whatever might hide in the waning days of the year.
As this healthy bounce boosts the market, I'm seeing opportunities in these special purpose acquisition companies.